IVXDB Stock Price and Chart — ASX:IVXDB

Overview

About INVION LIMITED

Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for cancers, atherosclerosis, and infectious diseases. The company was founded on October 11, 2000 and is headquartered in Melbourne, Australia.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

‪0.00‬

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange INVION LIMITED stocks are traded under the ticker IVXDB.

Today INVION LIMITED has the market capitalization of ‪13.63 M‬, it has decreased by −33.33% over the last week.

Yes, you can track INVION LIMITED financials in yearly and quarterly reports right on TradingView.

IVXDB net income for the last half-year is ‪−4.91 M‬ AUD, while the previous report showed ‪−714.17 K‬ AUD of net income which accounts for −588.01% change. Track more INVION LIMITED financial stats to get the full picture.

No, IVXDB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INVION LIMITED EBITDA is ‪−1.16 M‬ AUD, and current EBITDA margin is −131.59%. See more stats in INVION LIMITED financial statements.

Like other stocks, IVXDB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVION LIMITED stock right from TradingView charts — choose your broker and connect to your account.